Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) — Market Cap & Net Worth
Market Cap & Net Worth: Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452)
Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) has a market capitalization of $438.12 Million (CN¥2.99 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #13057 globally and #3873 in its home market, demonstrating a -0.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anhui Sunhere Pharmaceutical Excipients Co Ltd's stock price CN¥12.77 by its total outstanding shares 234456278 (234.46 Million). Also see 300452 current and non-current assets for a full breakdown of the balance sheet.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Market Cap History: 2015 to 2026
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $647.58 Million to $438.12 Million (-0.07% CAGR). Also see how efficiently does Anhui Sunhere Pharmaceutical Excipients generate cash for how efficiently the company converts equity into cash flow.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 300452 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.49x
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap is 0.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.60x
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap is 2.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $531.39 Million | $286.40 Million | $48.79 Million | 1.86x | 10.89x |
| 2017 | $368.39 Million | $339.36 Million | $50.34 Million | 1.09x | 7.32x |
| 2018 | $253.19 Million | $428.56 Million | $70.11 Million | 0.59x | 3.61x |
| 2019 | $286.35 Million | $464.07 Million | $84.37 Million | 0.62x | 3.39x |
| 2020 | $425.29 Million | $531.20 Million | $93.94 Million | 0.80x | 4.53x |
| 2021 | $546.42 Million | $616.71 Million | $89.25 Million | 0.89x | 6.12x |
| 2022 | $581.29 Million | $704.53 Million | $130.71 Million | 0.83x | 4.45x |
| 2023 | $479.23 Million | $839.26 Million | $161.54 Million | 0.57x | 2.97x |
| 2024 | $415.47 Million | $882.57 Million | $119.42 Million | 0.47x | 3.48x |
| 2025 | $459.05 Million | $942.80 Million | $176.55 Million | 0.49x | 2.60x |
Competitor Companies of 300452 by Market Capitalization
Companies near Anhui Sunhere Pharmaceutical Excipients Co Ltd in the global market cap rankings as of September 19, 2026. Review Anhui Sunhere Pharmaceutical Excipients (300452) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Anhui Sunhere Pharmaceutical Excipients Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap moved from $647.58 Million to $ 438.12 Million, with a yearly change of -0.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥438.12 Million | -4.56% |
| 2025 | CN¥459.05 Million | +10.49% |
| 2024 | CN¥415.47 Million | -13.30% |
| 2023 | CN¥479.23 Million | -17.56% |
| 2022 | CN¥581.29 Million | +6.38% |
| 2021 | CN¥546.42 Million | +28.48% |
| 2020 | CN¥425.29 Million | +48.52% |
| 2019 | CN¥286.35 Million | +13.10% |
| 2018 | CN¥253.19 Million | -31.27% |
| 2017 | CN¥368.39 Million | -30.68% |
| 2016 | CN¥531.39 Million | -17.94% |
| 2015 | CN¥647.58 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Anhui Sunhere Pharmaceutical Excipients Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $438.12 Million USD |
| MoneyControl | $438.12 Million USD |
| MarketWatch | $438.12 Million USD |
| marketcap.company | $438.12 Million USD |
| Reuters | $438.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anhui Sunhere Pharmaceutical Excipients Co Ltd
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.